Sellas Life Sciences Stock Total Debt
| SLS Stock | USD 1.22 0.02 1.61% |
Sellas Life Sciences fundamentals help investors to digest information that contributes to Sellas Life's financial success or failures. It also enables traders to predict the movement of Sellas Stock. The fundamental analysis module provides a way to measure Sellas Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sellas Life stock.
Total Debt To Capitalization is likely to drop to 0.06 in 2024. Sellas | Total Debt |
Sellas Life Sciences Company Total Debt Analysis
Sellas Life's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Sellas Life Total Debt | 906 K |
Most of Sellas Life's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sellas Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Sellas Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Sellas Life is extremely important. It helps to project a fair market value of Sellas Stock properly, considering its historical fundamentals such as Total Debt. Since Sellas Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sellas Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sellas Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Sellas Total Debt Historical Pattern
Today, most investors in Sellas Life Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sellas Life's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Sellas Life total debt as a starting point in their analysis.
Sellas Life Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Sellas Net Debt
Net Debt |
|
Based on the latest financial disclosure, Sellas Life Sciences has a Total Debt of 906 K. This is 99.97% lower than that of the Biotechnology sector and 99.72% lower than that of the Health Care industry. The total debt for all United States stocks is 99.98% higher than that of the company.
Sellas Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sellas Life's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sellas Life could also be used in its relative valuation, which is a method of valuing Sellas Life by comparing valuation metrics of similar companies.Sellas Life is currently under evaluation in total debt category among its peers.
Sellas Life Institutional Holders
Institutional Holdings refers to the ownership stake in Sellas Life that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Sellas Life's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Sellas Life's value.| Shares | Springbok Capital Management, Llc | 2024-06-30 | 55.7 K | Lpl Financial Corp | 2024-06-30 | 51.9 K | Mariner Wealth Advisors Llc | 2024-06-30 | 44.9 K | Jane Street Group Llc | 2024-06-30 | 28 K | Charles Schwab Investment Management Inc | 2024-09-30 | 16.2 K | Commonwealth Equity Services Inc | 2024-06-30 | 15.6 K | Wedbush Morgan Securities Inc | 2024-06-30 | 15 K | Calton & Associates, Inc. | 2024-09-30 | 14 K | Tower Research Capital Llc | 2024-06-30 | 13.6 K | Vanguard Group Inc | 2024-09-30 | 2.3 M | Geode Capital Management, Llc | 2024-06-30 | 517 K |
Sellas Fundamentals
| Return On Equity | -8.88 | ||||
| Return On Asset | -1.29 | ||||
| Current Valuation | 66.82 M | ||||
| Shares Outstanding | 70.38 M | ||||
| Shares Owned By Insiders | 0.24 % | ||||
| Shares Owned By Institutions | 7.36 % | ||||
| Number Of Shares Shorted | 8.61 M | ||||
| Price To Book | 5.49 X | ||||
| Price To Sales | 26.90 X | ||||
| Gross Profit | 900 K | ||||
| EBITDA | 529 K | ||||
| Net Income | (37.34 M) | ||||
| Cash And Equivalents | 26.99 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 906 K | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 2.36 X | ||||
| Book Value Per Share | (0.25) X | ||||
| Cash Flow From Operations | (31.41 M) | ||||
| Short Ratio | 14.07 X | ||||
| Earnings Per Share | (0.67) X | ||||
| Target Price | 5.83 | ||||
| Number Of Employees | 16 | ||||
| Beta | 2.4 | ||||
| Market Capitalization | 85.87 M | ||||
| Total Asset | 6.22 M | ||||
| Retained Earnings | (217.24 M) | ||||
| Working Capital | (10.56 M) | ||||
| Net Asset | 6.22 M |
About Sellas Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sellas Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sellas Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sellas Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.